SCHEMBL5073759

SCHEMBL5073759

CCC1(CC)OCC(C=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7479352 1.00
SCHEMBL9130929 0.79 TDP1 (0.37)
SCHEMBL13822372 0.79 TDP1 (0.37)
SCHEMBL13001895 0.72
SCHEMBL12976171 0.72
SCHEMBL367022 0.71
SCHEMBL2257240 0.71
SCHEMBL367023 0.71
SCHEMBL6765480 0.71 MMP9 (0.35)
SCHEMBL10618639 0.70 GRIN1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2000501738-A 2000-02-15 JP claimed
US-5756775-A Process to make α,α-difluoro-β-hydroxyl thiol esters ELI LILLY AND COMPANY (US) 1998-05-26 US claimed
WO-1997021719-A1 α, α-DIFLUORO-β-HYDROXY THIOL ESTERS AND THEIR SYNTHESIS ELI LILLY AND COMPANY (US) 1997-06-19 WO claimed
EP-0779275-A2 Alpha, Alpha - Difluoro-beta -hydroxy thiol esters and their synthesis ELI LILLY AND COMPANY (US) 1997-06-18 EP claimed
US-20080119421-A1 Process for treating a biological organism TECHNOLOGY INNOVATIONS, LLC 2008-05-22 US disclosed
CN-1222519-C Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2005-10-12 CN disclosed
US-20050215764-A1 Biological polymer with differently charged portions TECHNOLOGY INNOVATIONS, LLC 2005-09-29 US disclosed
US-6835734-B2 (S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, useful as intermediates for the preparation of levodropropizine Dompé S.p.A. (IT) 2004-12-28 US disclosed
EP-1307441-B1 1,3-DIOXOLANES WITH ANTITUSSIVE ACTIVITY DOMPE SPA (IT) 2004-05-06 EP disclosed
US-20040038989-A1 1,3-dioxolanes with antitussive activity DOMPÉ FARMACEUTICI S.P.A. (IT) 2004-02-26 US disclosed
EP-1147101-B1 REVERSE HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LAB (US) 2002-11-20 EP disclosed
EP-1258486-A2 Process for preparing 2,2-difluoroketene silyl o,s-acetals and alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid o,s-esters ELI LILLY AND COMPANY (US) 2002-11-20 EP disclosed
US-6001994-A Process for making gemcitabine hydrochloride ELI LILLY AND COMPANY (US) 1999-12-14 US disclosed
US-5912366-A CHEMICAL INTERMEDIATES FOR GEMCITABINE AN ANTITUMOR AGENT ELI LILLY AND COMPANY (US) 1999-06-15 US disclosed
US-5756775-A Process to make α,α-difluoro-β-hydroxyl thiol esters ELI LILLY AND COMPANY (US) 1998-05-26 US disclosed
EP-0779275-A2 Alpha, Alpha - Difluoro-beta -hydroxy thiol esters and their synthesis ELI LILLY AND COMPANY (US) 1997-06-18 EP disclosed
US-5618951-A REACTING A CHLORODIFLUOROACETATE WITH A HALOSILANE USING AN UREA SILVENT AND A REDUCING AGENT ELI LILLY AND COMPANY (US) 1997-04-08 US disclosed
EP-0677527-A1 Process for preparing 2,2-difluoroketene silyl O,S-acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O,S-esters ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed
US-5428176-A Contacting a difluorothioacetate with a halosilane in presence of reducing agent ELI LILLY AND COMPANY (US) 1995-06-27 US disclosed
EP-0655454-A1 Process for preparing 2,2-difluoroketene silyl acetals and a,a-difluoro-b-silyloxy-1,3-dioxolane-4-propanoic acid esters ELI LILLY AND COMPANY (US) 1995-05-31 EP disclosed